Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity

被引:24
作者
Goffin, W
Demonté, D
Vanhulle, C
de Walque, S
de Launoit, Y
Burny, A
Collette, Y
Van Lint, C
机构
[1] Univ Libre Bruxelles, Serv Chim Biol, Inst Biol & Med Mol, Mol Virol Lab, B-6041 Gosselies, Belgium
[2] Free Univ Brussels, Mol Virol Lab, Fac Med, B-1070 Brussels, Belgium
[3] Univ Lille 1, CNRS, Inst Pasteur Lille, Inst Biol Lille,UMR 8117, F-59021 Lille, France
[4] INSERM, U119, F-13009 Marseille, France
关键词
D O I
10.1093/nar/gki720
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously identified in the pol gene of human immunodeficiency virus type 1 (HIV-1) a new positive transcriptional regulatory element (nt 4481-4982) containing recognition sites for nuclear proteins (sites B, C, D and a GC-box) [C. Van Lint, J. Ghysdael, P. Paras, Jr, A. Burny and E. Verdin (1994) J. Virol 68, 2632-2648]. In this study, we have further physically characterized each binding site and have shown that the transcription factors Oct-1, Oct-2, PU.1, Sp1 and Sp3 interact in vitro with the pol region. Chromatin immunoprecipitation assays using HIV-infected cell lines demonstrated in the context of chromatin that Sp1, Sp3, Oct-1 and PU.1 are recruited to the HS7 region in vivo. For each site, we have identified mutations abolishing factor binding to their cognate DNA sequences without altering the underlying amino acid sequence of the integrase. By transient transfection assays, we have demonstrated the involvement of the pol binding sites in the transcriptional enhancing activity of the intragenic region. Our functional results with multimerized wild-type and mutated pol binding sites separately (i.e. in the absence of the other sites) have demonstrated that the PU.1, Sp1, Sp3 and Oct-1 transcription factors regulate the transcriptional activity of a heterologous promoter through their respective HS7 binding sites. Finally, we have investigated the physiological role of the HS7 binding sites in HIV-1 replication and have shown that these sites are important for viral infectivity.
引用
收藏
页码:4285 / 4310
页数:26
相关论文
共 74 条
[11]   The synthetic immunomodulator Murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells [J].
Darcissac, ECA ;
Truong, MJ ;
Dewulf, J ;
Mouton, Y ;
Capron, A ;
Bahr, GM .
JOURNAL OF VIROLOGY, 2000, 74 (17) :7794-7802
[12]   Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat [J].
Dekoninck, A ;
Calomme, C ;
Nizet, S ;
de Launoit, Y ;
Burny, A ;
Ghysdael, J ;
Van Lint, C .
ONCOGENE, 2003, 22 (19) :2882-2896
[13]   CELL-TYPE-SPECIFIC CONTROL ELEMENTS OF THE LYMPHOTROPIC PAPOVAVIRUS ENHANCER [J].
ERSELIUS, JR ;
JOSTES, B ;
HATZOPOULOS, AK ;
MOSTHAF, L ;
GRUSS, P .
JOURNAL OF VIROLOGY, 1990, 64 (04) :1657-1666
[14]   Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells - Association with the activated phenotype [J].
Firulli, AB ;
Miano, JM ;
Bi, WZ ;
Johnson, D ;
Casscells, W ;
Olson, EN ;
Schwarz, JJ .
CIRCULATION RESEARCH, 1996, 78 (02) :196-204
[15]   FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS [J].
GALLO, RC ;
SALAHUDDIN, SZ ;
POPOVIC, M ;
SHEARER, GM ;
KAPLAN, M ;
HAYNES, BF ;
PALKER, TJ ;
REDFIELD, R ;
OLESKE, J ;
SAFAI, B ;
WHITE, G ;
FOSTER, P ;
MARKHAM, PD .
SCIENCE, 1984, 224 (4648) :500-503
[16]   Impaired ossification in mice lacking the transcription factor Sp3 [J].
Göllner, H ;
Dani, C ;
Phillips, B ;
Philipsen, S ;
Suske, G .
MECHANISMS OF DEVELOPMENT, 2001, 106 (1-2) :77-83
[17]   SP1-MEDIATED TRANSCRIPTIONAL ACTIVATION IS REPRESSED BY SP3 [J].
HAGEN, G ;
MULLER, S ;
BEATO, M ;
SUSKE, G .
EMBO JOURNAL, 1994, 13 (16) :3843-3851
[18]  
HAN TH, 1995, MOL CELL BIOL, V15, P2907
[19]   DIFFERENTIAL GROWTH-KINETICS ARE EXHIBITED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAR MUTANTS [J].
HARRICH, D ;
HSU, C ;
RACE, E ;
GAYNOR, RB .
JOURNAL OF VIROLOGY, 1994, 68 (09) :5899-5910
[20]  
HATZOPOULOS AK, 1990, DEVELOPMENT, V109, P349